Illumina, Inc. (ILMN) capitalization

Current snapshot

Market Cap
$17.80B
151.3M shares × $117.67 · as of last filing 2026-03-29
Net Worth
$2.68B
Stockholders' equity · 2026-03-29
Enterprise Value
$19.19B
Market cap + debt − cash
Net Debt
$1.39B
Debt $2.54B − Cash $1.16B

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-28 $21.05B
FY'24 2024-12-29 $21.51B
FY'23 2023-12-31 $22.00B
FY'22 2023-01-01 $31.75B
FY'21 2022-01-02 $57.45B
FY'20 2021-01-03 $54.76B
FY'19 2019-12-29 $49.51B
FY'18 2018-12-30 $44.44B
FY'17 2017-12-31 $32.34B
FY'16 2017-01-01 $18.95B
FY'15 2016-01-03 $28.60B
FY'14 2014-12-28 $28.04B
FY'13 2013-12-29 $15.45B
FY'12 2012-12-30 $7.32B
FY'10 2011-01-02 $9.09B
FY'10 2010-01-03 $4.21B
FY'10 2008-12-28 $3.39B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-29 $18.12B
Q4'25 2025-12-28 $20.65B
Q3'25 2025-09-28 $14.12B
Q2'25 2025-06-29 $14.88B
Q1'25 2025-03-30 $12.72B
Q4'24 2024-12-29 $21.51B
Q3'24 2024-09-29 $20.82B
Q2'24 2024-06-30 $16.60B
Q1'24 2024-03-31 $21.83B
Q4'23 2023-12-31 $22.14B
Q3'23 2023-10-01 $21.69B
Q2'23 2023-07-02 $29.62B
Q1'23 2023-04-02 $36.74B
Q4'22 2023-01-01 $31.95B
Q3'22 2022-10-02 $29.95B
Q2'22 2022-07-03 $29.99B
Q1'22 2022-04-03 $57.86B
Q4'21 2022-01-02 $59.73B
Q3'21 2021-10-03 $60.41B
Q2'21 2021-07-04 $69.79B
Q1'21 2021-04-04 $56.60B
Q4'20 2021-01-03 $54.02B
Q3'20 2020-09-27 $44.38B
Q2'20 2020-06-28 $53.29B
Q1'20 2020-03-29 $39.82B
Q4'19 2019-12-29 $48.85B
Q3'19 2019-09-29 $44.59B
Q2'19 2019-06-30 $54.85B
Q1'19 2019-03-31 $46.29B
Q1'19 2018-12-31
Q4'18 2018-12-30 $43.84B
Q3'18 2018-09-30 $54.69B
Q2'18 2018-07-01 $41.33B
Q1'18 2018-04-01 $34.99B
Q4'17 2017-12-31 $32.12B
Q3'17 2017-10-01 $29.48B
Q2'17 2017-07-02 $25.51B
Q1'17 2017-04-02 $25.08B
Q4'16 2017-01-01 $18.69B
Q3'16 2016-10-02 $26.89B
Q2'16 2016-07-03 $20.83B
Q1'16 2016-04-03 $24.70B
Q4'15 2016-01-03 $28.14B
Q3'15 2015-09-27 $26.27B
Q2'15 2015-06-28 $32.48B
Q1'15 2015-03-29 $27.83B
Q4'14 2014-12-28 $27.03B
Q3'14 2014-09-28 $24.40B
Q2'14 2014-06-29 $25.75B
Q1'14 2014-03-30 $21.39B
Q4'13 2013-12-29 $14.10B
Q3'13 2013-09-29 $11.39B
Q2'13 2013-06-30 $10.43B
Q1'13 2013-03-31 $6.68B
Q4'12 2012-12-30 $6.79B
Q3'12 2012-09-30 $6.39B
Q2'12 2012-07-01 $5.37B
Q1'12 2012-04-01 $7.04B
Q3'11 2012-01-01 $4.23B
Q3'11 2011-10-02 $5.56B
Q2'11 2011-07-03 $10.78B
Q1'11 2011-04-03 $10.84B
Q4'10 2011-01-02 $8.02B
Q3'10 2010-10-03 $7.13B
Q2'10 2010-07-04 $6.07B
Q1'11 2010-04-04 $5.36B
Q4'10 2010-01-03 $4.21B
Q3'10 2009-09-27 $5.69B
Q2'10 2009-06-28 $5.32B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (ILMN CIK 0001110803), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

CBL

CBL & ASSOCIATES PROPERTIES, INC.

KPTI

Karyopharm Therapeutics Inc.

SOLV

SOLVENTUM CORPORATION